A study of the efficacy and safety of MPC-SHRC for the relief of symptoms associated with uncomplicated urinary tract infections.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Enrollment
200
Oral tablet four times a day for 3 days
Oral tablet four times a day for 3 days
First Urology PSC
Jeffersonville, Indiana, United States
Beyer Research
Kalamazoo, Michigan, United States
Lawrence OB/GYN Clinical Research, LLC
Lawrenceville, New Jersey, United States
Women's Health Research Center
Plainsboro, New Jersey, United States
Change from baseline on assessment instrument
Patient reported outcome
Time frame: 6 hours after the first dose of study drug
Change from baseline on assessment instruments
Patient reported outcome
Time frame: Three hour intervals after first dose of study drug
Change from baseline on Pain Scale
Patient reported outcome
Time frame: Three hour intervals after first dose of study drug
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.